No Data
No Data
Express News | Telomir Pharmaceuticals Shares Down 12.57% at $4.45 in Premarket Trade; White Diamind Research Says It Has a Strong Sell Rating on the Stock
Express News | Telomir Pharmaceuticals Announced It Raised $1M In Equity Funding Through Starwood Trust
Telomir Pharmaceuticals Enters Into Stock Purchase Agreement
Telomir Pharmaceuticals Raises $1M At $7 Per Share In No-warrant, Restricted Common Stock Deal - Filing
Individual Investors Are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners and Were Rewarded After Market Cap Rose by US$75m Last Week
Why Is Telomir Pharmaceuticals Stock Trading Higher On Tuesday?